Jeil Pharma Holdings

제일파마홀딩스 · 002620

Industrials Commercial Services · KOSPI

Small-cap

Market cap US$85.5M (₩118B)

Overview

Jeil Pharma Holdings is listed on KOSPI, South Korea's main stock exchange.

Its official filing does not provide sufficient detail in the available text to describe its specific products, services, or supply-chain role with confidence. The company name suggests a holding-company structure in a pharma-related field, but no product or operational details can be confirmed from the filing text provided.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$476.5M

▼ −15.7% YoY

Operating profit · FY2025

US$28M

Turned profitable

Net income · FY2025

US$25.1M

Turned profitable

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$582.6M(₩804B)	US$565.1M(₩779.8B)	US$476.5M(₩657.6B)
Operating profit	US$15.1M(₩20.8B)	−US$8.4M(−₩11.6B)	US$28M(₩38.7B)
Net income	−US$9.6M(−₩13.2B)	−US$48.1M(−₩66.4B)	US$25.1M(₩34.6B)

Revenue

FY2023US$582.6M
FY2024US$565.1M
FY2025US$476.5M

Operating profit

FY2023US$15.1M
FY2024−US$8.4M
FY2025US$28M

Net income

FY2023−US$9.6M
FY2024−US$48.1M
FY2025US$25.1M

Key ratios (FY2025)

ROE

7.4%

Debt/Eq

86.9%

Op. margin

5.9%

Net margin

5.3%

Rev. YoY

▼ −15.7%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?